Implementation, feasibility, and acceptability of 99DOTS-based supervision of treatment for drug-susceptible TB in Uganda

Implementation, feasibility, and acceptability of 99DOTS-based supervision of treatment for drug-susceptible TB in Uganda

Show other versions (1)

99DOTS is a low-cost digital adherence technology that allows people with tuberculosis (TB) to self-report treatment adherence. There are limited data on its implementation, feasibility, and acceptability from sub-Saharan Africa. We conducted a longitudinal analysis and cross-sectional surveys neste...

Full description

Bibliographic Details
Main Authors:	Noah Kiwanuka, Alex Kityamuwesi, Rebecca Crowder, Kevin Guzman, Christopher A. Berger, Maureen Lamunu, Catherine Namale, Lynn Kunihira Tinka, Agnes Sanyu Nakate, Joseph Ggita, Patricia Turimumahoro, Diana Babirye, Denis Oyuku, Devika Patel, Amanda Sammann, Stavia Turyahabwe, David W. Dowdy, Achilles Katamba, Adithya Cattamanchi
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-06-01
Series:	PLOS Digital Health
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313004/?tool=EBI

Similar Items

Implementation, feasibility, and acceptability of 99DOTS-based supervision of treatment for drug-susceptible TB in Uganda.
by: Noah Kiwanuka, et al.
Published: (2023-06-01)

Study protocol and implementation details for a pragmatic, stepped-wedge cluster randomised trial of a digital adherence technology to facilitate tuberculosis treatment completion
by: Noah Kiwanuka, et al.
Published: (2020-11-01)

Variation in tuberculosis treatment outcomes and treatment supervision practices in Uganda
by: Christopher A. Berger, et al.
Published: (2020-12-01)

Barriers and Facilitators to Implementing a Digital Adherence Technology for Tuberculosis Treatment Supervision in Uganda: Qualitative Study
by: Anna Leddy, et al.
Published: (2023-05-01)

Iterative Adaptation of a Tuberculosis Digital Medication Adherence Technology to Meet User Needs: Qualitative Study of Patients and Health Care Providers Using Human-Centered Design Methods
by: Patel, Devika, et al.
Published: (2020-12-01)

Evaluating the impact of cash transfers on tuberculosis (ExaCT TB): a stepped wedge cluster randomised controlled trial
by: Priya B. Shete, et al.
Published: (2023-06-01)

Feasibility of a social protection linkage program for individuals at-risk for tuberculosis in Uganda.
by: Grace Nanyunja, et al.
Published: (2023-01-01)

Feasibility of a social protection linkage program for individuals at-risk for tuberculosis in Uganda
by: Grace Nanyunja, et al.
Published: (2023-01-01)

A user-centred implementation strategy for tuberculosis contact investigation in Uganda: protocol for a stepped-wedge, cluster-randomised trial
by: Katamba, Achilles, et al.
Published: (2023)

A user-centred implementation strategy for tuberculosis contact investigation in Uganda: protocol for a stepped-wedge, cluster-randomised trial
by: Achilles Katamba, et al.
Published: (2023-08-01)

Design and execution of a public randomization ceremony to enhance stakeholder engagement within a cluster randomized trial to improve tuberculosis diagnosis in Uganda
by: Tania F. Reza, et al.
Published: (2021-06-01)

Drop-out from the tuberculosis contact investigation cascade in a routine public health setting in urban Uganda: A prospective, multi-center study.
by: Mari Armstrong-Hough, et al.
Published: (2017-01-01)

Theory-Informed Design of a Tailored Strategy for Implementing Household TB Contact Investigation in Uganda
by: J. Lucian Davis, et al.
Published: (2022-03-01)

mHealth to improve implementation of TB contact investigation: a case study from Uganda
by: Amanda J. Gupta, et al.
Published: (2023-06-01)

Implementation science to improve the quality of tuberculosis diagnostic services in Uganda
by: Adithya Cattamanchi, et al.
Published: (2020-02-01)

Home-based tuberculosis contact investigation in Uganda: a household randomised trial
by: J. Lucian Davis, et al.
Published: (2019-07-01)

A cost analysis of implementing mobile health facilitated tuberculosis contact investigation in a low-income setting.
by: Patricia Turimumahoro, et al.
Published: (2022-01-01)

Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.
by: Fred C Semitala, et al.
Published: (2024-02-01)

Population-level impact of same-day microscopy and Xpert MTB/RIF for tuberculosis diagnosis in Africa.
by: David W Dowdy, et al.
Published: (2013-01-01)

Feasibility of a short message service (SMS) intervention to deliver tuberculosis testing results in peri-urban and rural Uganda
by: Diana Babirye, et al.
Published: (2019-08-01)

Patient and health system level barriers to and facilitators for tuberculosis treatment initiation in Uganda: a qualitative study
by: Stella Zawedde-Muyanja, et al.
Published: (2022-06-01)

Patient and health system factors associated with pretreatment loss to follow up among patients diagnosed with tuberculosis using Xpert® MTB/RIF testing in Uganda
by: Stella Zawedde-Muyanja, et al.
Published: (2020-12-01)

Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda—patient and health worker perspectives
by: Fred C. Semitala, et al.
Published: (2021-06-01)

Protocol for the 3HP Options Trial: a hybrid type 3 implementation-effectiveness randomized trial of delivery strategies for short-course tuberculosis preventive therapy among people living with HIV in Uganda
by: Jillian L. Kadota, et al.
Published: (2020-08-01)

Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial.
by: Allan Musinguzi, et al.
Published: (2024-01-01)

Performance evaluation of Truenat MTB and Truenat MTB-RIF DX assays in comparison to gene XPERT MTB/RIF ultra for the diagnosis of pulmonary tuberculosis in Uganda
by: Willy Ssengooba, et al.
Published: (2024-02-01)

Is distance associated with tuberculosis treatment outcomes? A retrospective cohort study in Kampala, Uganda
by: Katherine O. Robsky, et al.
Published: (2020-06-01)

Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.
by: Fred C Semitala, et al.
Published: (2021-12-01)

Feasibility of a multifaceted intervention to improve treatment initiation among patients diagnosed with TB using Xpert MTB/RIF testing in Uganda.
by: Stella Zawedde-Muyanja, et al.
Published: (2022-01-01)

Acceptability and feasibility of digital adherence technologies for drug-susceptible tuberculosis treatment supervision: A meta-analysis of implementation feedback.
by: Kevin Guzman, et al.
Published: (2023-08-01)

Quality of care for patients evaluated for tuberculosis in the context of Xpert MTB/RIF scale-up
by: Katherine Farr, et al.
Published: (2019-05-01)

Incremental yield of serial sputum cultures for diagnosis of tuberculosis among HIV infected smear negative pulmonary TB suspects in Kampala, Uganda.
by: Willy Ssengooba, et al.
Published: (2012-01-01)

Sputum quality and diagnostic performance of GeneXpert MTB/RIF among smear-negative adults with presumed tuberculosis in Uganda.
by: Amanda J Meyer, et al.
Published: (2017-01-01)

Evaluation of Xpert MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda.
by: Achilles Katamba, et al.
Published: (2023-01-01)

Estimating the effect of pretreatment loss to follow up on TB associated mortality at public health facilities in Uganda.
by: Stella Zawedde-Muyanja, et al.
Published: (2020-01-01)

Readiness to implement on-site molecular testing for tuberculosis in community health centers in Uganda
by: Talemwa Nalugwa, et al.
Published: (2022-02-01)

Estimating the effect of pretreatment loss to follow up on TB associated mortality at public health facilities in Uganda
by: Stella Zawedde-Muyanja, et al.
Published: (2020-01-01)

Is aggregated surveillance data a reliable method for constructing tuberculosis care cascades? A secondary data analysis from Uganda.
by: Elizabeth B White, et al.
Published: (2022-01-01)

Pre-diagnosis and pre-treatment loss to follow-up and associated factors among patients with presumed tuberculosis and those diagnosed in Uganda
by: Rebecca Nuwematsiko, et al.
Published: (2024-12-01)

Study protocol: a cluster randomized trial to evaluate the effectiveness and implementation of onsite GeneXpert testing at community health centers in Uganda (XPEL-TB)
by: Tania F. Reza, et al.
Published: (2020-04-01)